Sinha P, Folefac C, Overgaard J, Horsman M
Cancers (Basel). 2024; 16(23).
PMID: 39682105
PMC: 11640455.
DOI: 10.3390/cancers16233916.
Kejik Z, Hajduch J, Abramenko N, Vellieux F, Vesela K, Leischner Fialova J
Commun Chem. 2024; 7(1):180.
PMID: 39138299
PMC: 11322665.
DOI: 10.1038/s42004-024-01256-6.
Carlton H, Arepally N, Healy S, Sharma A, Ptashnik S, Schickel M
Nanomaterials (Basel). 2024; 14(12).
PMID: 38921935
PMC: 11206764.
DOI: 10.3390/nano14121059.
Overchuk M, Weersink R, Wilson B, Zheng G
ACS Nano. 2023; 17(9):7979-8003.
PMID: 37129253
PMC: 10173698.
DOI: 10.1021/acsnano.3c00891.
Vaupel P, Piazena H, Notter M, Thomsen A, Grosu A, Scholkmann F
Cancers (Basel). 2023; 15(5).
PMID: 36900190
PMC: 10000497.
DOI: 10.3390/cancers15051394.
Validation of a Temperature-Feedback Controlled Automated Magnetic Hyperthermia Therapy Device.
Sharma A, Jangam A, Low Yung Shen J, Ahmad A, Arepally N, Rodriguez B
Cancers (Basel). 2023; 15(2).
PMID: 36672278
PMC: 9856953.
DOI: 10.3390/cancers15020327.
Recent Strategies to Address Hypoxic Tumor Environments in Photodynamic Therapy.
Du Y, Han J, Jin F, Du Y
Pharmaceutics. 2022; 14(9).
PMID: 36145513
PMC: 9505114.
DOI: 10.3390/pharmaceutics14091763.
Accurate Three-Dimensional Thermal Dosimetry and Assessment of Physiologic Response Are Essential for Optimizing Thermoradiotherapy.
Dewhirst M, Oleson J, Kirkpatrick J, Secomb T
Cancers (Basel). 2022; 14(7).
PMID: 35406473
PMC: 8997141.
DOI: 10.3390/cancers14071701.
Hyperthermia: The Optimal Treatment to Overcome Radiation Resistant Hypoxia.
Elming P, Sorensen B, Oei A, Franken N, Crezee J, Overgaard J
Cancers (Basel). 2019; 11(1).
PMID: 30634444
PMC: 6356970.
DOI: 10.3390/cancers11010060.
Magnetic Hyperthermia and Radiation Therapy: Radiobiological Principles and Current Practice .
Spirou S, Basini M, Lascialfari A, Sangregorio C, Innocenti C
Nanomaterials (Basel). 2018; 8(6).
PMID: 29865277
PMC: 6027353.
DOI: 10.3390/nano8060401.
Recommendations for In Vitro and In Vivo Testing of Magnetic Nanoparticle Hyperthermia Combined with Radiation Therapy.
Spirou S, Costa Lima S, Bouziotis P, Vranjes-Djuric S, Efthimiadou E, Laurenzana A
Nanomaterials (Basel). 2018; 8(5).
PMID: 29734795
PMC: 5977320.
DOI: 10.3390/nano8050306.
Magnetic hyperthermia therapy for the treatment of glioblastoma: a review of the therapy's history, efficacy and application in humans.
Mahmoudi K, Bouras A, Bozec D, Ivkov R, Hadjipanayis C
Int J Hyperthermia. 2018; 34(8):1316-1328.
PMID: 29353516
PMC: 6078833.
DOI: 10.1080/02656736.2018.1430867.
Enhanced Radiotherapy using Bismuth Sulfide Nanoagents Combined with Photo-thermal Treatment.
Cheng X, Yong Y, Dai Y, Song X, Yang G, Pan Y
Theranostics. 2017; 7(17):4087-4098.
PMID: 29158812
PMC: 5694999.
DOI: 10.7150/thno.20548.
Fever-range hyperthermia vs. hypothermia effect on cancer cell viability, proliferation and HSP90 expression.
Kalamida D, Karagounis I, Mitrakas A, Kalamida S, Giatromanolaki A, Koukourakis M
PLoS One. 2015; 10(1):e0116021.
PMID: 25635828
PMC: 4312095.
DOI: 10.1371/journal.pone.0116021.
Hyperthermia as adjunct to intravesical chemotherapy for bladder cancer.
Owusu R, Abern M, Inman B
Biomed Res Int. 2013; 2013:262313.
PMID: 24073396
PMC: 3773892.
DOI: 10.1155/2013/262313.
Hyperthermia versus Oncothermia: Cellular Effects in Complementary Cancer Therapy.
Hegyi G, Szigeti G, Szasz A
Evid Based Complement Alternat Med. 2013; 2013:672873.
PMID: 23662149
PMC: 3638606.
DOI: 10.1155/2013/672873.
Mild temperature hyperthermia and radiation therapy: role of tumour vascular thermotolerance and relevant physiological factors.
Griffin R, Dings R, Jamshidi-Parsian A, Song C
Int J Hyperthermia. 2010; 26(3):256-63.
PMID: 20210610
PMC: 2909325.
DOI: 10.3109/02656730903453546.
Kadota Fund International Forum 2004. Application of thermal stress for the improvement of health, 15-18 June 2004, Awaji Yumebutai International Conference Center, Awaji Island, Hyogo, Japan. Final report.
Sugahara T, van der Zee J, Kampinga H, Vujaskovic Z, Kondo M, Ohnishi T
Int J Hyperthermia. 2008; 24(2):123-40.
PMID: 18283589
PMC: 2765467.
DOI: 10.1080/02656730701883675.
Augmentation in chemosensitivity of intratumor quiescent cells by combined treatment with nicotinamide and mild hyperthermia.
Masunaga S, Ono K, AKABOSHI M, Kawai K, Suzuki M, Kinashi Y
Jpn J Cancer Res. 1997; 88(8):770-7.
PMID: 9330609
PMC: 5921498.
DOI: 10.1111/j.1349-7006.1997.tb00449.x.
Reduction of hypoxic cells in solid tumours induced by mild hyperthermia: special reference to differences in changes in the hypoxic fraction between total and quiescent cell populations.
Masunaga S, Ono K, AKABOSHI M, Nishimura Y, Suzuki M, Kinashi Y
Br J Cancer. 1997; 76(5):588-93.
PMID: 9303356
PMC: 2228014.
DOI: 10.1038/bjc.1997.430.